This study is actively recruiting.
Description: Join a Clinical Research Study. For adolescents 12 to 16 years old diagnosed with schizophrenia
Seven visits conveniently scheduled at Kennedy Krieger Institute over 10 weeks
Each visit lasts from 2 to 3 hours
There is compensation for time and travel for each visit
The purpose of the study is to determine if study drug Na-Ben (sodium benzoate), added on to existing treatment, is safe and effective.
Eligibility & Criteria
IRB # 00030540
Principal Investigator: Robert Findling, MD, MBS
Study Sponsor: SyneuRX International (Taiwan) Corp.
Eligible Age Range:12 – 16 years
Gender: All
Diagnosis: Schizophrenia
Contact: To learn more, call the Clinical Trials Unit: Kennedy Krieger Institute—(443) 923-3850
Email: ResearchTrials@kennedykrieger.org
Keyword: schizophrenia